Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-017-1673-6
Abstract: PurposeFavorable long-term outcomes of the Zilver PTX drug-eluting stent (DES) in femoropopliteal lesions have been demonstrated. Chronic renal failure (CRF) has been shown to be a risk factor for restenosis and decreased limb salvage. The… read more here.
Keywords: without crf; study; patients crf; market surveillance ... See more keywords
Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2022.2088965
Abstract: Abstract Objectives Antiproliferative therapies based on paclitaxel have been developed to extend the durability of endovascular interventions for lower-extremity atherosclerotic peripheral artery disease, resulting in improved primary vessel patency and fewer target lesion revascularizations. This… read more here.
Keywords: zilver ptx; paclitaxel; cost; cost effectiveness ... See more keywords
Safety of Zilver PTX Drug-Eluting Stent Implantation Following Drug-Coated Balloon Dilation in a Healthy Swine Model
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Endovascular Therapy"
DOI: 10.1177/1526602817743747
Abstract: Purpose: To compare the safety of Zilver PTX drug-eluting stents (DES) following drug-coated balloon (DCB) angioplasty or conventional balloon angioplasty (BA) in a healthy porcine iliofemoral artery model. Methods: DES implantation following DCB (DCB+DES) or… read more here.
Keywords: safety; drug; balloon; implantation ... See more keywords
Full Drug-Eluting Stent Jacket: Two-Year Results of a Single-Center Experience With Zilver PTX Stenting for Long Lesions in the Femoropopliteal Arteries
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Endovascular Therapy"
DOI: 10.1177/1526602818762805
Abstract: Purpose: To evaluate the 1- and 2-year patency and reintervention rates with the Zilver PTX drug-eluting stent (DES) in long complex femoropopliteal disease. Methods: A retrospective review was conducted of 89 consecutive patients (mean age… read more here.
Keywords: drug eluting; lesion; year; long lesions ... See more keywords